These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Emergence of CD52-, glycosylphosphatidylinositol-anchor-deficient lymphocytes in rheumatoid arthritis patients following Campath-1H treatment. Brett SJ; Baxter G; Cooper H; Rowan W; Regan T; Tite J; Rapson N Int Immunol; 1996 Mar; 8(3):325-34. PubMed ID: 8671618 [TBL] [Abstract][Full Text] [Related]
4. Synovial tissue response to treatment with Campath-1H. Ruderman EM; Weinblatt ME; Thurmond LM; Pinkus GS; Gravallese EM Arthritis Rheum; 1995 Feb; 38(2):254-8. PubMed ID: 7531440 [TBL] [Abstract][Full Text] [Related]
5. Emergence of oligoclonal T cell populations following therapeutic T cell depletion in rheumatoid arthritis. Jendro MC; Ganten T; Matteson EL; Weyand CM; Goronzy JJ Arthritis Rheum; 1995 Sep; 38(9):1242-51. PubMed ID: 7575719 [TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody treatment in rheumatoid arthritis: the clinical and immunological effects of a CD7 monoclonal antibody. Kirkham BW; Pitzalis C; Kingsley GH; Chikanza IC; Sabharwal S; Barbatis C; Grahame R; Gibson T; Amlot PL; Panayi GS Br J Rheumatol; 1991 Dec; 30(6):459-63. PubMed ID: 1720991 [TBL] [Abstract][Full Text] [Related]
7. The CD45 tyrosine phosphatase regulates Campath-1H (CD52)-induced TCR-dependent signal transduction in human T cells. Hederer RA; Guntermann C; Miller N; Nagy P; Szollosi J; Damjanovich S; Hale G; Alexander DR Int Immunol; 2000 Apr; 12(4):505-16. PubMed ID: 10744652 [TBL] [Abstract][Full Text] [Related]
8. Rheumatoid Arthritis--heresies and speculations. Fox DA Perspect Biol Med; 1997; 40(4):479-91. PubMed ID: 9269739 [No Abstract] [Full Text] [Related]